[PRESS RELEASE] – STAMFORD, Conn., Sept. 8, 2025 – Curaleaf Holdings Inc., a leading international provider of consumer cannabis products, announced that it has been selected for inclusion into the S&P/TSX Composite Index under the health care sector, effective prior to the open of trading on Sept. 22, 2025.
The inclusion of the company in the TSX Composite Index places it amongst the most capitalized and actively traded companies on the Toronto Stock Exchange. As the first U.S.-based cannabis operator to be included in the S&P/TSX Composite Index, the company is poised to gain increased visibility and credibility within one of North America’s premier equity benchmarks.
“This marks a pivotal moment for Curaleaf and represents a significant moment for mainstream normalization across the broader cannabis industry,” Curaleaf Chairman and CEO Boris Jordan said. “Being recognized among some of the most influential stocks in North America, and as the only U.S.-based cannabis operator currently in this index, validates our sector’s growing legitimacy and long-term potential.
The inclusion of our company reflects a greater presence in the public market and enables us to access institutional investors and index linked vehicles, as well as potential regulatory triggers. The dedication of our team has driven this success, and I want to thank the Curaleaf Team for all their hard work.